L Verdian

492 total citations
20 papers, 332 citations indexed

About

L Verdian is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Finance. According to data from OpenAlex, L Verdian has authored 20 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pediatrics, Perinatology and Child Health, 5 papers in Psychiatry and Mental health and 4 papers in Finance. Recurrent topics in L Verdian's work include Epilepsy research and treatment (5 papers), Healthcare Systems and Reforms (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). L Verdian is often cited by papers focused on Epilepsy research and treatment (5 papers), Healthcare Systems and Reforms (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). L Verdian collaborates with scholars based in United Kingdom, United States and Brazil. L Verdian's co-authors include Annabel Nixon, Katy Gallop, Lynne Pezzullo, Joyce A. Cramer, D Wild, Fernando Bacal, Joseph B. Barney, Cicely Kerr, Richard Beale and Grant Maclaine and has published in prestigious journals such as Critical Care Medicine, Value in Health and PharmacoEconomics.

In The Last Decade

L Verdian

18 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Verdian United Kingdom 10 140 114 50 46 44 20 332
Sarah Gallagher Australia 9 184 1.3× 97 0.9× 34 0.7× 23 0.5× 15 0.3× 11 484
Steven J. Baumrucker United States 10 40 0.3× 67 0.6× 32 0.6× 52 1.1× 16 0.4× 84 428
Patricia Sacco United States 13 103 0.7× 86 0.8× 24 0.5× 45 1.0× 12 0.3× 27 579
Rahul Rastogi United States 9 57 0.4× 22 0.2× 39 0.8× 24 0.5× 44 1.0× 22 395
L. Rousseau Canada 5 66 0.5× 20 0.2× 53 1.1× 76 1.7× 8 0.2× 5 333
Zoe Moon United Kingdom 12 44 0.3× 72 0.6× 13 0.3× 132 2.9× 4 0.1× 33 499
Willem Woertman Netherlands 6 20 0.1× 29 0.3× 40 0.8× 65 1.4× 41 0.9× 10 355
Jayne Hardicre United Kingdom 11 69 0.5× 10 0.1× 56 1.1× 64 1.4× 11 0.3× 28 364
María José Robles Spain 11 87 0.6× 17 0.1× 24 0.5× 46 1.0× 4 0.1× 28 249
Wanning Xu China 6 73 0.5× 13 0.1× 50 1.0× 91 2.0× 17 0.4× 8 403

Countries citing papers authored by L Verdian

Since Specialization
Citations

This map shows the geographic impact of L Verdian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Verdian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Verdian more than expected).

Fields of papers citing papers by L Verdian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Verdian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Verdian. The network helps show where L Verdian may publish in the future.

Co-authorship network of co-authors of L Verdian

This figure shows the co-authorship network connecting the top 25 collaborators of L Verdian. A scholar is included among the top collaborators of L Verdian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Verdian. L Verdian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pezzullo, Lynne, et al.. (2018). The Economic Burden of Heart Conditions in Brazil. Arquivos Brasileiros de Cardiologia. 111(1). 29–36. 39 indexed citations
2.
Pezzullo, Lynne, et al.. (2018). The economic burden of hypertension, heart failure, myocardial infarction, and atrial fibrillation in Mexico. Archivos de cardiología de México. 88(3). 241–244. 15 indexed citations
3.
Pezzullo, Lynne, et al.. (2017). The Economic Burden of Heart Conditions in Brazil. Arquivos Brasileiros de Cardiologia. 38 indexed citations
4.
Stevens, Barbara C., et al.. (2016). The Economic Burden of Hypertension in Latin America. Value in Health. 19(7). A647–A648. 3 indexed citations
5.
Stevens, Barbara C., et al.. (2016). The Economic Burden of Four Heart Conditions in Latin America. Value in Health. 19(7). A648–A648. 1 indexed citations
6.
Stevens, Barbara C., et al.. (2016). The Economic Burden of Heart Failure in Latin America. Value in Health. 19(7). A645–A645. 1 indexed citations
7.
Stevens, Barbara C., et al.. (2016). The Economic Burden of Myocardial Infarction in Latin America. Value in Health. 19(7). A646–A646.
8.
Verdian, L, et al.. (2016). PM021 The Economic Burden of Heart Diseases in Colombia. Global Heart. 11(2). e73–e74. 2 indexed citations
9.
Pezzullo, Lynne, et al.. (2016). PM019 The Economic Burden of Heart Diseases in Mexico. Global Heart. 11(2). e72–e73. 1 indexed citations
10.
Gallop, Katy, Cicely Kerr, Annabel Nixon, et al.. (2014). A Qualitative Investigation of Patients’ and Caregivers’ Experiences of Severe Sepsis*. Critical Care Medicine. 43(2). 296–307. 52 indexed citations
11.
Khan, Nasreen, Dhvani Shah, Vanita Tongbram, L Verdian, & Neil Hawkins. (2013). The efficacy and tolerability of perampanel and other recently approved anti-epileptic drugs for the treatment of refractory partial onset seizure: a systematic review and Bayesian network meta-analysis. Current Medical Research and Opinion. 29(8). 1001–1013. 16 indexed citations
12.
Benedict, Ágnes, L Verdian, & Grant Maclaine. (2010). The Cost Effectiveness of Rufinamide in the Treatment of Lennox-Gastaut Syndrome in the UK. PharmacoEconomics. 28(3). 185–199. 19 indexed citations
13.
Gallop, Katy, D Wild, L Verdian, et al.. (2009). Lennox-Gastaut Syndrome (LGS): Development of conceptual models of health-related quality of life (HRQL) for caregivers and children. Seizure. 19(1). 23–30. 47 indexed citations
14.
Gallop, Katy, D Wild, Annabel Nixon, L Verdian, & Joyce A. Cramer. (2009). Impact of Lennox-Gastaut Syndrome (LGS) on health-related quality of life (HRQL) of patients and caregivers: Literature review. Seizure. 18(8). 554–558. 53 indexed citations
16.
Eldabe, Sam, et al.. (2009). Eliciting health state utilities from the general public for severe chronic pain. The European Journal of Health Economics. 11(3). 323–330. 9 indexed citations
17.
Dewilde, Sarah, et al.. (2009). Cost-effectiveness of ziconotide in intrathecal pain management for severe chronic pain patients in the UK. Current Medical Research and Opinion. 25(8). 2007–2019. 13 indexed citations
18.
19.
Yi, Yu Hyeon, et al.. (2008). PND22 ELICITING UTILITY SCORES FOR HEALTH STATES ASSOCIATED WITH LENNOX-GASTAUT SYNDROME. Value in Health. 11(6). A606–A606. 2 indexed citations
20.
Lloyd, Andrew R., Masaki Meguro, Sarah Dewilde, Grant Maclaine, & L Verdian. (2007). PPN11 ELICITING UTILITY SCORES FOR HEALTH STATES ASSOCIATED WITH SEVERE CHRONIC PAIN. Value in Health. 10(6). A467–A467. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026